Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2015

Open Access 01-12-2015 | Research article

Analysis on evolution and research focus in psychiatry field

Authors: Ying Wu, Zhiguang Duan

Published in: BMC Psychiatry | Issue 1/2015

Login to get access

Abstract

Background

With the dramatic rise in mental disorders and mental illnesses, psychiatry has become one of the fastest growing clinical medical disciplines. This has led to a rise in the number of scientific research papers being published in this field.

Methods

We selected research papers in ten psychiatric journals that were published during 1983 to 2012. These ten journals were those with the top Impact Factor (IF) as indicated by the Science Citation Index Expanded (SCI-Expanded). We utilized information visualization software (CiteSpace) to conduct co-citation and Hierarchal clustering analysis to map knowledge domains to determine the evolution and the foci of research in this field.

Results

In the evolution of the field of psychiatry, there were four stages identified. The result of hierarchal clustering analysis revealed that the research foci in the psychiatric field were primarily studies of child and adolescent psychiatry, diagnostic and classification criteria, brain imaging and molecular genetics.

Conclusion

The results provide information about the evolution and the foci of the research in the field of psychiatry. This information can help researchers determine the direction of the research in the field of psychiatry; Moreover, this research provides reasonable suggestions to guide research in psychiatry field and provide scientific evidence to aid in the effective prevention and treatment of mental disorders.
Literature
1.
Geng L. Mental health human resource status and development. Chinese Hospitals. 2007;11(3):37–40.
2.
Shu L. Guide to prevention and treatment of schizophrenia in China. BeiJing: Peking University Medical Press; 2007.
3.
Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science. 1996;274(5288):740–3.PubMed
4.
Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorder in the World Health Surveys. JAMA. 2004;291(21):2581–90.PubMed
5.
Small H. Co‐citation in the scientific literature: A new measure of the relationship between two documents. J Am Soc Inf Sci. 1973;24(4):265–9.
6.
Marshakova IV. System of connections between documents based on references (as the Science Citation Index). Nauchno-Tekhnicheskaya Informatsiya. Seriya. 1973;2(6):3–8.
7.
Synnestvedt MB, Chen CM, Holmes JH. Holomes. CiteSpace: Visualization and Knowledge Discovery in Bibliograpic Databases. AMIA Annu Symp Proc.2005; 724–8.
8.
Chen CM. CiteSpaceII: Detecting and Visualizing Emerging T rends and Transient Patterns in Scientific Literature. J Am Soc Inf Sci Technol. 2006;57:359–77.
9.
Liu ZY, Chen Y, Hou HY. et, al. Mapping Knowledge Domains Methods and Application. BeiJing: People’s Publishing House; 2008.
10.
Kraepelin E. Psychological work experiments. Zeitschrift fur die gesamte neurologie und psychiatrie. 1921;70:230–40.
11.
Overall JE, Gorham DR. The Brief Psychiatric Rating-Scale. Psychol Rep. 1962;10(3):799–812.
12.
Spitzer RL, Endicott J, Robins E. Clinical criteria for psychiatric diagnosis and DSM-III. Am J Psychiatry. 1975;132(11):1187–92.PubMed
13.
14.
Andreasen NC. Negative V, positive schizophrenia-definition and Validation. Arch Gen Psychiatry. 1982;39(7):789–94.PubMed
15.
Golden CJ, Moses JA, Zelazowski R. Cerebral Ventricular Size and Neuropychological Impairment in Young chronic Schizophrenics. Arch Gen Psychiatry. 1980;37(6):619–23.PubMed
16.
Wolkin A, Jaeger J, Brodie JD. Persistence of Cerebral in chronic schizophrenia as determined by positron emission tomography. Am J of Psychiatry. 1985;142(5):564–71.
17.
Carney MWP, Roth M, Garside RF. The diagnosis of depressive syndromes and the prediction of E.C.T response. Brit J. Psychiatry. 1965;111(475):659–74.
18.
Vaughn CE, Leff JP. The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients. Brit J Psychiatry. 1976;129(8):125–37.
19.
Carroll BJ, Feinberg M, Greden JF. A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry. 1981;38(1):15–22.PubMed
20.
Hamilton M. The assessment of anxiety states by rating. Brit J Med Psychology. 1959;32(1):50–5.
21.
Hamilton M. A rating scale for depression. J Neurol Neurosur psychiatry. 1960;23(1):56–62.
22.
Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278.PubMed
23.
Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta psychiatrica Scandinavica. Supplementum. 1970;212:11–9.
24.
Endicott J, Spitzer RL. A diagnostic interview-the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35(7):837–44.PubMed
25.
Kovelman JA, Scheibel AB. A neurohistological correlate of schizophrenia. Biol Psychiatry. 1984;19(12):1601–21.PubMed
26.
Bogerts B, Meertz E, Schonfeldtbausch R. Basal ganglia and limbic system pathology in schizophrenia. Arch Gen Psychiatry. 1985;42(8):784–91.PubMed
27.
Weinberger DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry. 1986;43(2):114–24.PubMed
28.
Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44(7):660–9.PubMed
29.
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulltin. 1987;13(2):261–76.
30.
Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the Treatment-resistant schizophrenic. Arch Gen Psyciatry. 1988;45(9):789–96.
31.
Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry. 1989;46(7):587–99.PubMed
32.
Shenton ME, Kikinis R, Jolesz FA, Pollak SD, Lemay M, Wible CG, et al. Abnormalities of the left temporal-lobe and thought–disorder in schizophrenia-a quantitative magnetic-resonance-imaging study. New Engl J Med. 1992;327(9):604–12.PubMed
33.
Mayberg HS, Liotti M, Brannan SK, Mcginnis S, Mahurin RK, Jerabek PA, et al. Reciprocal limbic-cortical function and negative mood: converging PET finding sin depression and normal sadness. Am J Psychiatry. 1999;156(5):675–82.PubMed
34.
LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000;23:155–84.PubMed
35.
Phan KL, Wager T, Taylor SF. Functional neuroanatomy of emotion: A Mata analysis of emotion activation studies in PET and fMRI. Neuroimage. 2002;16(2):331–48.PubMed
36.
Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion PerceptionI:the neural basis of normal emotion perception. Biol Psychiatry. 2003;54(5):504–14.PubMed
37.
Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651–60.PubMed
38.
Borgwardt SJ, Riecher-Roessler A, Dazzan P, Chitnis X, Aston J, Drewe M, et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry. 2007;61(10):1148–56.PubMed
39.
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. Effect of COMT Val (108/158) Met genotype on frontal lobe function and risk for schizophrenia. P Natl Acad Sci USA. 2001;98(12):6917–22.
40.
Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320(5875):539–43.PubMed
41.
Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460(7256):748–52.PubMed
42.
Baxter LR, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder-a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1987;44(3):211–8.PubMed
43.
Spitzer RL, Endicott J, Robins E, et al. Research diagnostic criteria-rationale and reliability. Arch Gen Psychiatry. 1978;35(6):773–82.PubMed
44.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin Phenol Reagent. J Biol Chem. 1951;193(1):265–75.PubMed
45.
Ballenger JC, Post RM. Carbamazepin in manic –depressive illness: a new treatment. Am J Psychiatry. 1980;137(7):782–90.PubMed
46.
Murphy JM, Monson RR, Laird NM, Sobol AM, Leighton AH. A comparison of diagnostic interview for depression in the stirling county study: challenge for psychiatric epidemiology. Arch Gen Psychiatry. 2000;57(3):230–6.PubMed
47.
Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwabstone ME, et al. The NIMH Diagnostic Interview Schedule for Children Version 2.3(DISC-2.3): Description, acceptability, prevalence rates and performance in the MECA study. J Am Acad Child Psychiatry. 1996;35(7):865–77.
48.
Grant S, London ED, Newlin DB, Villemagne VL, Lin X, Contoreggi C, et al. Activation of memory circuits during cue- elicited cocaine craving. P Natl Aca Sci USA. 1996;93(21):12040–5.
49.
Folstein MF, Folstein SE, Mchugh PR. Min-mental state practical method for grading for cognitive state of patients for clinician. J Psychiatr Res. 1975;12(3):189–98.PubMed
50.
Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1-Dopamine and D2-dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine relation to extrapyramidal side effects. Arch Gen Psychiatry. 1992;49(7):538–44.PubMed
51.
Rechts CA, Kales A. A manual of standardized terminology techniques and scoring system for sleep stages of Human subjects USA National Institute Health Publication 204 book. LosAngeles, CA: Brain Information Service, UCLA; 1968.
52.
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of Anxiety –related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274(5292):1527–31.PubMed
53.
Mears AJ, Collins C, Mirzayans F, Myambok, Wernick M, Kuo WL, et al. Physical and genetic mapping of the IGDA locus at 6p25. Am J Hum Genet. 1997;61(4):A285.
54.
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for affective disorders and schizophrenia for school-age children present and life time version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Psychiatry. 1997;36(7):980–8.
55.
Santarelli L, Saxe M, Gross C. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301(5634):805–9.PubMed
56.
Rey M, Dellatolas G, Bancaud J, Talairach J. Hemispheric lateralization of motor and speech functions after early brain lesion-study of 73 epileptic patients with intracarotid amytal test. Neuropsychologia. 1988;26(1):167–72.PubMed
57.
Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160(4):636–45.PubMed
58.
Ji JL, Wu WY. Psychiatry. 2nd ed. ShangHai: FuDan University Press; 2009.
59.
Foster A, Miller DD, Buckley P. Pharmacogenetics and schizophrenia. Clin Lab Med. 2010;30:975–93.PubMed
60.
Gupta S, Jain S, Brahmachari SK. Pharmacogenomics: a path to predictive medicine for schizophrenia. Pharmacogenomics. 2006;7:31–47.PubMed
Metadata
Title
Analysis on evolution and research focus in psychiatry field
Authors
Ying Wu
Zhiguang Duan
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2015
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-015-0482-1

Other articles of this Issue 1/2015

BMC Psychiatry 1/2015 Go to the issue

Research article

Natural course of behavioral addictions: a 5-year longitudinal study

Study protocol

Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study

Study protocol

Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study)

Research article

Contribution of estradiol levels and hormonal contraceptives to sex differences within the fear network during fear conditioning and extinction

Research article

A comparison of clinical characteristics between adolescent males and females with eating disorders

Research article

Differential characteristics of young and midlife adult users of psychotherapy, psychotropic medications, or both: information from a population representative sample in São Paulo, Brazil